Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Vertex Pharmaceuticals Incorporated (VRTX) had Stock-Based Compensation of $333.40M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.96B |
|
$1.03B |
|
$407.50M |
|
$2.56B |
|
$1.81B |
|
$1.15B |
|
$131.90M |
|
$1.28B |
|
$1.28B |
|
$1.03B |
|
$1.03B |
|
$1.03B |
|
$1.03B |
|
$1.15B |
|
$1.20B |
|
256.70M |
|
258.90M |
|
$4.02 |
|
$3.99 |
|
| Balance Sheet Financials | |
$10.43B |
|
$1.34B |
|
$13.61B |
|
$24.04B |
|
$4.14B |
|
-- |
|
$2.72B |
|
$6.86B |
|
$17.18B |
|
$15.65B |
|
$17.18B |
|
256.29M |
|
| Cash Flow Statement Financials | |
$1.89B |
|
$-540.30M |
|
$-1.03B |
|
$4.57B |
|
$4.98B |
|
$409.80M |
|
|
Stock-Based Compensation |
$333.40M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.25% |
|
38.83% |
|
38.83% |
|
-- |
|
43.28% |
|
34.84% |
|
$1.71B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.27 |
|
1.57 |
|
57.48 |
|
6.01% |
|
6.60% |
|
4.30% |
|
6.01% |
|
$67.01 |
|
$6.59 |
|
$7.31 |
|